December 6, 2022
Via: The Wall Street JournalEmergent BioSolutions Inc., maker of Narcan, a nasal-spray form of naloxone, said Tuesday that the U.S. Food and Drug Administration fast-tracked an application it submitted for an over-the-counter version of its widely used opioid-reversal nasal spray. The company said it […]
July 9, 2024
June 25, 2024